[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100344297":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":22,"locations":10,"responsibleParty":32,"collaborators":10,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":10,"eligibilityCriteria":39,"healthyVolunteers":40,"sex":41,"minAge":42,"maxAge":10,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":10,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":54,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":10},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Exposure group：Benign gallbladder disease",null,"Patients with benign gallbladder diseases, such as gallbladder polyps, gallstones, etc.",[13],"Other: Benigh gallbladder diseases",{"label":15,"type":10,"description":16,"interventionNames":10},"Non-exposed group: healthy people","Patients without benign gallbladder diseases",[18],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"Benigh gallbladder diseases","We aim to observe the relationship between the benigh gallbladder diseases and gallbladder cancer, and we will not take any actions to interrupt.",[9],[23,28],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Jianming Wang, PHD","CONTACT","+86 13507188252","wjm18jgm@aliyun.com",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Yun Lu, MD","+86 13971543825","drlyly@163.com",{"type":33,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100344297","multicenter-prospective-cohort-study-of-risk-factors-for-gallbladder-cancer-100344297",false,"NCT03762837","Multicenter Prospective Cohort Study of Risk Factors for Gallbladder Cancer","Inclusion Criteria:\n\n* Subjects who met the following four criteria entered the study.\n\n  1. A benign gallbladder disease is detected during a medical examination or visit (according to any imaging test);\n  2. healthy people without gallbladder disease;\n  3. Age greater than 18 years and less than 80 years old;\n  4. Sign the informed consent form. PS: If someone meets the condition (1) or (2), then he can be enrolled.\n\nExclusion Criteria:\n\n* Subjects can not enter the study by combining any of the following\n\n  1. Concomitant diseases such as severe mental illness, severe heart, lung and kidney;\n  2. Refusal of follow-up requirements.",true,"ALL","18 Years",{"count":44,"type":45},100000,"ESTIMATED","10 Years","OBSERVATIONAL","This trial is a prospective study, the main purpose of the study is to investigate the association between benign gallbladder disease and gallbladder carcinoma; to explain the timing of intervention, intervention and early prevention of benign gallbladder disease; according to the national epidemiology of gallbladder cancer Center Clinical Research (unpublished), 2000 National Cholecystoma Clinical Epidemiology Report, and 2005 Clinical Analysis of 2379 Cases of Gallbladder Carcinoma in 17 Hospitals in Five Northwest Provinces, Pre-experimental data, using samples The volume estimation formula, α = 0.05, β = 0.1, plans to enroll 100,000 people.Half of participants is someone with Biliary benign disease，while the other half is healthy.",[50,51],"Gallbladder Diseases","Healthy",[53],"Gallbladder cancer","NOT_YET_RECRUITING","2019-02-28",{"date":57,"type":58},"2019-03-04","ACTUAL",{"date":60,"type":45},"2019-04-01",{"date":62,"type":45},"2029-12-31",{"name":5,"class":6}]